ArticleFrontiers in pharmacology2026
Posterior reversible encephalopathy syndrome across 22 VEGF-pathway inhibitors in the FDA adverse event reporting system: reporting patterns and reporting-interval characteristics.
Ji Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.